Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.
African American
Hispanic American
cohort studies
dementia
mild cognitive impairment
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
2
3
2021
medline:
15
9
2021
entrez:
1
3
2021
Statut:
ppublish
Résumé
Variability in dementia rates across racial and ethnic groups has been estimated at 60%. Studies suggest disparities in Caribbean Hispanic and Black populations, but community-based data are limited. Estimate the prevalence of mild cognitive impairment (MCI) and dementia in the racially and ethnically diverse community-based Northern Manhattan Study cohort and examine sociodemographic, vascular risk factor, and brain imaging correlates. Cases of MCI and dementia were adjudicated by a team of neuropsychologists and neurologists and prevalence was estimated across race/ethnic groups. Ordinal proportional odds models were used to estimate race/ethnic differences in the prevalence of MCI or dementia adjusting for sociodemographic variables (model 1), model 1 plus potentially modifiable vascular risk factors (model 2), and model 1 plus structural imaging markers of brain integrity (model 3). There were 989 participants with cognitive outcome determinations (mean age 69±9 years; 68% Hispanic, 16% Black, 14% White; 62% women; mean (±SD) follow-up five (±0.6) years). Hispanic and Black participants had greater likelihood of MCI (20%) and dementia (5%) than White participants accounting for age and education differences. Hispanic participants had greater odds of MCI or dementia than both White and Black participants adjusting for sociodemographic variables, vascular risk factors, and brain imaging factors. White matter hyperintensity burden was significantly associated with greater odds of MCI or dementia (OR = 1.3, 1.1 to 1.6), but there was no significant interaction by race/ethnicity. In this diverse community-based cohort, cross-sectional data revealed significant race/ethnic disparities in the prevalence of MCI and dementia. Longer follow-up and incidence data are needed to further clarify these relationships.
Sections du résumé
BACKGROUND
Variability in dementia rates across racial and ethnic groups has been estimated at 60%. Studies suggest disparities in Caribbean Hispanic and Black populations, but community-based data are limited.
OBJECTIVE
Estimate the prevalence of mild cognitive impairment (MCI) and dementia in the racially and ethnically diverse community-based Northern Manhattan Study cohort and examine sociodemographic, vascular risk factor, and brain imaging correlates.
METHODS
Cases of MCI and dementia were adjudicated by a team of neuropsychologists and neurologists and prevalence was estimated across race/ethnic groups. Ordinal proportional odds models were used to estimate race/ethnic differences in the prevalence of MCI or dementia adjusting for sociodemographic variables (model 1), model 1 plus potentially modifiable vascular risk factors (model 2), and model 1 plus structural imaging markers of brain integrity (model 3).
RESULTS
There were 989 participants with cognitive outcome determinations (mean age 69±9 years; 68% Hispanic, 16% Black, 14% White; 62% women; mean (±SD) follow-up five (±0.6) years). Hispanic and Black participants had greater likelihood of MCI (20%) and dementia (5%) than White participants accounting for age and education differences. Hispanic participants had greater odds of MCI or dementia than both White and Black participants adjusting for sociodemographic variables, vascular risk factors, and brain imaging factors. White matter hyperintensity burden was significantly associated with greater odds of MCI or dementia (OR = 1.3, 1.1 to 1.6), but there was no significant interaction by race/ethnicity.
CONCLUSION
In this diverse community-based cohort, cross-sectional data revealed significant race/ethnic disparities in the prevalence of MCI and dementia. Longer follow-up and incidence data are needed to further clarify these relationships.
Identifiants
pubmed: 33646162
pii: JAD201370
doi: 10.3233/JAD-201370
pmc: PMC8150441
mid: NIHMS1705760
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1129-1138Subventions
Organisme : NINDS NIH HHS
ID : R01 NS029993
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS029993
Pays : United States
Organisme : NINDS NIH HHS
ID : R56 NS029993
Pays : United States
Références
J Alzheimers Dis. 2017 Oct 3;60(3):1065-1075
pubmed: 28984588
Neurology. 2002 Aug 13;59(3):383-91
pubmed: 12177372
Neurology. 2019 Aug 20;93(8):e791-e803
pubmed: 31341005
Psychol Med. 1994 Feb;24(1):145-53
pubmed: 8208879
Neurology. 2015 Aug 4;85(5):441-9
pubmed: 26156514
Brain Cogn. 1997 Apr;33(3):343-56
pubmed: 9126399
Alzheimers Dement (Amst). 2016;2:1-11
pubmed: 26949733
Neurology. 2008 Feb 5;70(6):425-30
pubmed: 17898325
Arch Neurol. 2007 Apr;64(4):570-5
pubmed: 17420320
JAMA. 2019 Aug 13;322(6):524-534
pubmed: 31408137
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Clin Neuropsychol. 2000 Feb;14(1):38-55
pubmed: 10855058
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):50-56
pubmed: 28984639
JAMA. 2019 Aug 13;322(6):535-545
pubmed: 31408138
J Am Heart Assoc. 2018 Aug 21;7(16):e009544
pubmed: 30369305
Diabetes Care. 2020 May;43(5):1111-1117
pubmed: 32139382
Br J Clin Psychol. 1982 Feb;21(1):1-16
pubmed: 7126941
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
J Alzheimers Dis. 2015;47(1):129-36
pubmed: 26402761
J Magn Reson Imaging. 1996 May-Jun;6(3):519-28
pubmed: 8724419
Alzheimers Dement. 2016 Mar;12(3):216-24
pubmed: 26874595
Neurology. 2010 Sep 7;75(10):889-97
pubmed: 20820000
Alzheimers Dement. 2019 Dec;15(12):1507-1515
pubmed: 31753701
Arch Neurol. 2003 Oct;60(10):1385-9
pubmed: 14568808
Arch Neurol. 2008 Aug;65(8):1053-61
pubmed: 18695055
Dement Geriatr Cogn Disord. 2011;31(6):424-30
pubmed: 21757907
JAMA Neurol. 2017 Oct 1;74(10):1246-1254
pubmed: 28783817
Percept Mot Skills. 1993 Jun;76(3 Pt 2):1219-30
pubmed: 8337069
Stroke. 1998 Feb;29(2):380-7
pubmed: 9472878
Int J Geriatr Psychiatry. 1999 Jun;14(6):481-93
pubmed: 10398359
Stroke. 2005 Jan;36(1):50-5
pubmed: 15576652
Arch Neurol. 2007 Dec;64(12):1734-40
pubmed: 18071036
BMJ. 2013 Dec 19;347:f7051
pubmed: 24355614
Alzheimers Dement. 2017 Jan;13(1):72-83
pubmed: 27599209
JAMA Neurol. 2014 Jul 1;71(7):872-7
pubmed: 24821476
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825